Your browser is no longer supported. Please, upgrade your browser.
Settings
ABT Abbott Laboratories daily Stock Chart
ABT [NYSE]
Abbott Laboratories
IndexS&P 500 P/E53.90 EPS (ttm)1.40 Insider Own0.20% Shs Outstand1.76B Perf Week2.62%
Market Cap132.41B Forward P/E20.91 EPS next Y3.60 Insider Trans-18.49% Shs Float1.74B Perf Month7.78%
Income2.47B PEG5.02 EPS next Q0.61 Inst Own75.50% Short Float0.99% Perf Quarter8.29%
Sales30.58B P/S4.33 EPS this Y44.60% Inst Trans0.30% Short Ratio2.44 Perf Half Y18.56%
Book/sh17.45 P/B4.31 EPS next Y12.05% ROA1.30% Target Price79.66 Perf Year29.12%
Cash/sh4.29 P/C17.54 EPS next 5Y10.74% ROE3.00% 52W Range56.81 - 75.27 Perf YTD4.04%
Dividend1.28 P/FCF45.60 EPS past 5Y47.40% ROI2.20% 52W High-0.03% Beta1.12
Dividend %1.70% Quick Ratio1.10 Sales past 5Y7.50% Gross Margin58.50% 52W Low32.46% ATR1.34
Employees99000 Current Ratio1.40 Sales Q/Q12.10% Oper. Margin9.70% RSI (14)62.47 Volatility1.34% 1.79%
OptionableYes Debt/Eq0.77 EPS Q/Q4.00% Profit Margin3.00% Rel Volume1.13 Prev Close73.97
ShortableYes LT Debt/Eq0.63 EarningsJan 23 BMO Payout206.60% Avg Volume7.10M Price75.25
Recom1.90 SMA204.28% SMA506.28% SMA20012.26% Volume8,055,795 Change1.73%
Feb-07-19Reiterated BofA/Merrill Buy $73 → $81
Jan-02-19Downgrade Citigroup Neutral → Sell
Nov-30-18Upgrade Goldman Neutral → Buy
Oct-16-18Initiated Barclays Overweight $80
Jun-27-18Initiated Bernstein Outperform $73
Jan-30-18Reiterated Citigroup Neutral $59 → $64
Jan-25-18Upgrade William Blair Mkt Perform → Outperform
Jan-25-18Reiterated Stifel Buy $63 → $71
Jan-03-18Initiated Evercore ISI Outperform
Jan-02-18Upgrade Morgan Stanley Equal-Weight → Overweight
Jan-02-18Upgrade JP Morgan Neutral → Overweight
Oct-19-17Reiterated Stifel Buy $58 → $63
Oct-19-17Reiterated RBC Capital Mkts Outperform $55 → $60
Oct-06-17Resumed JP Morgan Neutral
Sep-28-17Reiterated Barclays Overweight $57 → $60
Aug-17-17Initiated Citigroup Neutral $53
Jun-29-17Resumed Jefferies Buy
Jun-29-17Initiated Guggenheim Buy $58
Jun-21-17Resumed BTIG Research Buy $56
May-16-17Initiated Goldman Neutral $45
Feb-15-19 09:33AM  Here's Why You Must Buy Cardiovascular Systems' (CSII) Stock Zacks
Feb-14-19 03:44PM  Johnson & Johnson (JNJ) to Acquire Auris Health for $3.4B Zacks
01:54PM  Quest Diagnostics (DGX) Q4 Earnings in Line, Margins Down Zacks
09:07AM  Baxter's Acute Therapies Profile Strong, Competition Rife Zacks
08:48AM  Bio-Techne (TECH) Q2 Earnings Beat, Gross Margin Declines Zacks
Feb-13-19 11:31PM  Quidel Corp (QDEL) Q4 2018 Earnings Conference Call Transcript Motley Fool
08:25AM  Boston Scientific Benefits From New Buyouts & Product Launch Zacks
08:16AM  Here's Why Investors Should Retain AmerisourceBergen Stock Zacks
08:13AM  Edwards Lifesciences to Buy CASMED to Boost Critical Care Arm Zacks
Feb-12-19 09:48AM  Here's Why Investors Should Retain Accuray (ARAY) Stock Now Zacks
09:09AM  Bruker (BRKR) Q4 Earnings In Line, Margin Growth Strong Zacks
08:39AM  Here's Why You Should Buy IDEXX Laboratories (IDXX) Stock Zacks
08:37AM  STERIS (STE) Q3 Earnings In Line, Revenues Beat Estimates Zacks
Feb-11-19 03:24PM  5 High-Growth Stocks Undervalued by the Market InvestorPlace
01:54PM  Final trades: Abbott Labs, Air Products, Twilio, Voya, & Colgate-Palmolive CNBC Videos
10:00AM  Here's Why Momentum Investors Will Love Abbott (ABT) Zacks
09:40AM  IRADIMED (IRMD) Q4 Earnings Surpass Estimates, Margins Up Zacks
08:41AM  Here's Why You Should Buy Wright Medical (WMGI) Stock Now Zacks
07:47AM  Top Ranked Momentum Stocks to Buy for February 11th Zacks
07:07AM  Does Abbott Laboratories (NYSE:ABT) Look Attractive Based On These Two Valuation Methods? Simply Wall St.
Feb-10-19 12:03PM  How to Fatten Up Your Portfolio By Investing in the Obesity Epidemic TheStreet.com
Feb-09-19 01:12AM  Weekly Top Insider Buys Highlight for the Week of Feb. 8 GuruFocus.com
Feb-08-19 01:53PM  Phirbo (PAHC) Q2 Earnings Lag Estimates, Operating Margin Up Zacks
11:04AM  The World's Top 10 Health Care Companies (UNH, MDT) Investopedia
09:48AM  Omnicell (OMCL) Q4 Earnings Beat Estimates, Revenues Miss Zacks
08:57AM  Here's Why You Should Invest in Stryker (SYK) Stock Right Now Zacks
04:10AM  [$$] Smith & Nephew in talks to buy NuVasive for over $3bn Financial Times
Feb-06-19 09:56AM  Here's Why You Should Invest in McKesson (MCK) Stock Now Zacks
05:00AM  Abbott- Diabetes and Diagnostics MoneyShow
Feb-05-19 07:00AM  Abbott Laboratories Director Is Buying Up Stock Barrons.com
Feb-04-19 04:40PM  Here's Why You Should Hold Intuitive Surgical (ISRG) Stock Zacks
Feb-03-19 09:00AM  Better Buy: Abbott Laboratories vs. DexCom Motley Fool
Feb-01-19 11:06AM  3 Medical Device Stocks Set to Test 52-Week Highs Investopedia
Jan-31-19 11:56AM  Surmodics (SRDX) Q1 Earnings & Revenues Beat, Guidance Solid Zacks
Jan-29-19 05:45PM  Abbott (ABT) Gains As Market Dips: What You Should Know Zacks
04:10PM  Medical Products Industry Outlook: Plenty of Upside Left Zacks
09:54AM  Here's Why You Should Snap Up Abbott (ABT) Stock Right Now Zacks
Jan-28-19 09:36AM  Abbott (ABT) Upgraded to Buy: Here's Why Zacks
09:27AM  Abbott Labs Falls 3% Investing.com
Jan-26-19 08:39AM  What Should We Expect From Abbott Laboratoriess (NYSE:ABT) Earnings Over The Next Year? Simply Wall St.
Jan-25-19 12:35PM  Shares of Abbott Laboratories Poised for Upside Breakout TheStreet.com
Jan-24-19 10:21PM  Edited Transcript of ABT earnings conference call or presentation 23-Jan-19 2:00pm GMT Thomson Reuters StreetEvents
12:13PM  Sell-Side Issues Positive Prognosis For Abbott Following Mixed Q4 Results, Strong 2019 Outlook Benzinga
12:09PM  FDA's warning could impact global market for cardiovascular devices Yahoo Finance
09:30AM  Company News For Jan 24, 2019 Zacks
02:43AM  Abbott (ABT) Q4 Earnings Meet Estimates, Organic Growth Solid Zacks
Jan-23-19 08:21PM  Hedge Fund Hooligans: Cramer's 'Mad Money' Recap (Wednesday 1/23/19) TheStreet.com
04:42PM  Abbott Labs (ABT) Stock Slips Despite Solid Q4 Earnings InvestorPlace
04:15PM  Abbott Slides On Revenue Lag, But Outlook Prods Drug Stocks Investor's Business Daily
04:09PM  Dow Rises as Wall Street Weighs Strong Earnings, Global Growth Concerns TheStreet.com
04:09PM  Abbott Labs Falls After Solid Earnings and Dividend Raise, Revenue Miss TheStreet.com
03:41PM  5 Must-See Stock Charts for Thursday: ABT, IBM, SBUX, PZZA InvestorPlace
02:36PM  Abbott misses revenue estimates, sees lackluster first-qtr profit Reuters
02:04PM  Healthcare ETFs Slip After Abbot Labs Revenue Miss, Weak Outlook ETF Trends
01:27PM  Abbott Laboratories (ABT) Q4 2018 Earnings Conference Call Transcript Motley Fool
10:12AM  US STOCKS-Wall Street bounces back on strong corporate earnings Reuters
10:09AM  Abbott Labs says M&A not a high priority now Reuters
09:11AM  US STOCKS-Wall St set to open higher on strong earnings from Dow members Reuters
09:10AM  [$$] Stocks to Watch: IBM, P&G, Synchrony The Wall Street Journal
09:00AM  Abbott (ABT) Meets Q4 Earnings Estimates Zacks
08:21AM  Abbott stock falls 2.7% after fourth-quarter revenue falls short MarketWatch
08:01AM  Abbott: 4Q Earnings Snapshot Associated Press
08:00AM  Today's Research Reports on Trending Tickers: Abbott Laboratories and Medtronic ACCESSWIRE
07:53AM  Abbott Lab's fourth-quarter revenue rises 2.3 pct Reuters
07:45AM  Abbott Reports 2018 Results and Issues Strong Forecast for 2019 PR Newswire
03:29AM  Stocks - IBM, P&G, United Tech, Comcast Soar in Premarket; Apple Rises Investing.com
02:50AM  Abbott Labs Earnings in Line, Revenue Misses In Q4 Investing.com
12:53AM  Top 5 Things to Know in The Market on Wednesday Investing.com
Jan-22-19 05:26PM  Abbott Laboratories Expected to Earn 81 cents a Share TheStreet.com
01:26PM  Abbott Laboratories Q4 Earnings Preview Benzinga
09:45AM  All Signals Are Positive for Buying Abbott Laboratories InvestorPlace
08:35AM  Medical Product Stocks' Earnings on Jan 23: ABT, NXGN & VAR Zacks
Jan-21-19 09:00AM  Abbott Offers a New Option for Physicians Treating Patients with Atrial Fibrillation PR Newswire
Jan-18-19 06:10PM  Cramer's game plan: This week, forecasts are more important than earnings CNBC
08:44AM  Can Medical Devices Strength Drive Abbott (ABT) Q4 Earnings? Zacks
08:43AM  Is a Surprise Coming for Abbott (ABT) This Earnings Season? Zacks
06:36AM  What Lies Ahead for Abbott (ABT) Stock This Earnings Season? Zacks
Jan-17-19 12:47PM  Here's Yana Barton's 2019 stock picks CNBC Videos
09:00AM  Japanese Red Cross Society Selects Abbott Technology to Screen Country's Blood and Plasma Supply PR Newswire
08:17AM  3 Weight-Loss Stocks in Focus on Rising Obesity Fears Zacks
05:00AM  Top Picks 2019- Abbott Laboratories ABT MoneyShow
Jan-16-19 03:04PM  3 Healthcare Stocks That Will Keep Your Portfolio Healthy InvestorPlace
10:30AM  Abbott (ABT) Earnings Expected to Grow: Should You Buy? Zacks
09:06AM  10 Profit-Rich Stocks for Lean Times Investopedia
09:00AM  Abbott To Acquire Cephea Valve Technologies, Inc. PR Newswire
Jan-15-19 09:30PM  3 Top Diabetes Stocks to Watch in January Motley Fool
10:10AM  Abbott Labs Rises 3% Investing.com
Jan-14-19 05:50PM  Abbott (ABT) Dips More Than Broader Markets: What You Should Know Zacks
09:00AM  FDA Approves World's First Device for Treatment of Premature Babies and Newborns with an Opening in Their Hearts (a Common Congenital Defect) PR Newswire
Jan-11-19 04:14PM  Why This Group Is 'An Attractive Destination For Investors' In 2019 Investor's Business Daily
03:45PM  3 Back-of-the-Shelf Consumer Stocks With Growth and Income InvestorPlace
08:00AM  Abbott and "Malaria No More" Work Together to End Malaria in Odisha, India PR Newswire
Jan-10-19 09:46AM  Zacks Value Trader Highlights: PayPal, Abbott Labs, UnitedHealth, Lam Research and Visa Zacks
07:52AM  Can We See Significant Institutional Ownership On The Abbott Laboratories (NYSE:ABT) Share Register? Simply Wall St.
Jan-09-19 05:14PM  These 5 Companies are Earnings Perfection Zacks
Jan-08-19 06:48AM  Abbott Labs Falls 3% Investing.com
Jan-07-19 05:50PM  Abbott (ABT) Outpaces Stock Market Gains: What You Should Know Zacks
10:56AM  As Patent Expirations Loom, the Clock Is Ticking on AbbVie Stock InvestorPlace
Jan-04-19 04:30PM  [$$] Angel Medical Wins Court Approval to Tap Bankruptcy Loan The Wall Street Journal
07:26AM  3 Big Stock Charts for Friday: Incyte, Schlumberger and Abbott Laboratories InvestorPlace
Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. The company's Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency; irritable bowel syndrome or biliary spasm; intrahepatic cholestasis or depressive symptoms; gynecological disorders; hormone replacement therapy; dyslipidemia; hypertension; hypothyroidism; Meniere's disease and vestibular vertigo; pain, fever, and inflammation; migraines; and anti-infective clarithromycin, as well as provides influenza vaccine and products that regulate physiological rhythm of the colon. Its Diagnostic Products segment offers core laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automates the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detects and measures infectious agents; cartridges for blood analysis; benchtop systems and rapid tests in the areas of infectious diseases; molecular point-of-care test systems for influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test systems, as well as remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The company's Nutritional Products segment provides pediatric and adult nutritional products. Its Cardiovascular and Neuromodulation Products segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company also provides blood and flash glucose monitoring systems, including test strips, sensors, data management decision software, and accessories for people with diabetes. The company was founded in 1888 and is headquartered in Abbott Park, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Contreras JaimeSenior Vice PresidentJan 31Option Exercise42.24140,1505,920,120231,798Feb 01 05:44 PM
Stratton John GDirectorJan 31Buy72.323,455249,8756,400Feb 01 05:43 PM
Contreras JaimeSenior Vice PresidentJan 30Option Exercise43.06214,1379,220,941269,105Feb 01 05:44 PM
Contreras JaimeSenior Vice PresidentJan 30Sale70.00177,45712,421,99091,648Feb 01 05:44 PM
WHITE MILES DChairman and CEONov 28Option Exercise26.02325,0008,454,8753,459,185Nov 30 05:02 PM
WHITE MILES DChairman and CEONov 28Sale72.585,519400,5823,134,185Nov 30 05:03 PM
WHITE MILES DChairman and CEONov 28Sale72.35142,34110,298,6103,316,844Nov 30 05:02 PM
WHITE MILES DChairman and CEONov 28Sale72.49177,14012,840,5983,139,704Nov 30 05:03 PM
Watkin JaredSenior Vice PresidentNov 02Option Exercise38.4065,0002,496,000128,640Nov 06 05:08 PM
Watkin JaredSenior Vice PresidentNov 02Sale71.0065,0004,615,00063,640Nov 06 05:08 PM
Bracken Sharon JSenior Vice PresidentSep 28Sale73.351,732127,04439,029Oct 02 06:58 PM
Salvadori Daniel Gesua SiveExecutive Vice PresidentSep 28Sale73.395,000366,95788,521Oct 02 06:58 PM
Blaser Brian JExecutive Vice PresidentSep 20Option Exercise27.4358,2001,596,165195,018Sep 21 05:02 PM
Blaser Brian JExecutive Vice PresidentSep 20Sale68.7958,2004,003,862136,818Sep 21 05:02 PM
Funck Robert ESenior Vice PresidentSep 05Option Exercise25.2436,400918,727145,080Sep 07 05:15 PM
Contreras JaimeSenior Vice PresidentAug 29Option Exercise37.67172,4686,496,984222,904Aug 31 05:04 PM
Contreras JaimeSenior Vice PresidentAug 29Sale66.8464,2684,295,39554,968Aug 31 05:05 PM
Contreras JaimeSenior Vice PresidentAug 29Sale66.7495,7936,393,590127,111Aug 31 05:04 PM
LANE ANDREW HExecutive Vice PresidentAug 29Sale67.119,097610,51326,583Aug 31 05:03 PM
Bracken Sharon JSenior Vice PresidentJul 30Sale65.1661540,07340,761Jul 31 05:01 PM
CAPEK JOHN MExecutive Vice PresidentJul 25Option Exercise26.0264,9001,688,374363,200Jul 26 05:05 PM
CAPEK JOHN MExecutive Vice PresidentJul 25Sale65.0064,9004,218,500298,300Jul 26 05:05 PM
PEDERSON MICHAEL JSenior Vice PresidentJul 24Sale63.5080350,99178,417Jul 24 05:02 PM
Blaser Brian JExecutive Vice PresidentJul 24Sale63.9615,100965,789136,818Jul 26 05:09 PM
PEDERSON MICHAEL JSenior Vice PresidentJul 23Sale63.2024715,61079,220Jul 24 05:02 PM
Bracken Sharon JSenior Vice PresidentJul 23Sale63.2025916,36941,376Jul 24 05:01 PM
Funck Robert ESenior Vice PresidentJun 05Option Exercise26.0212,800332,992117,293Jun 07 05:08 PM
Salvadori Daniel Gesua SiveExecutive Vice PresidentMay 18Sale61.501,00061,50094,581May 21 05:16 PM
Salvadori Daniel Gesua SiveExecutive Vice PresidentMay 17Sale61.052,000122,09295,581May 21 05:16 PM
Bracken Sharon JSenior Vice PresidentMay 04Sale58.562,150125,90942,140May 08 05:00 PM
Contreras JaimeSenior Vice PresidentApr 23Sale59.3684950,3972,595Apr 25 05:12 PM
BIRD ROGERSenior Vice PresidentMar 09Sale62.758,262518,45058,174Mar 13 05:03 PM
Watkin JaredSenior Vice PresidentMar 07Sale61.193,000183,57965,515Mar 09 05:01 PM
Bracken Sharon JSenior Vice PresidentMar 05Sale60.272,100126,55944,290Mar 07 05:11 PM
Fussell Stephen RExecutive Vice PresidentMar 01Sale60.1311,106667,804161,052Mar 02 05:17 PM
Salvadori Daniel Gesua SiveExecutive Vice PresidentMar 01Sale58.9790553,36997,581Mar 02 05:15 PM
Watkin JaredSenior Vice PresidentMar 01Sale58.8799658,63568,515Mar 02 05:15 PM
MANNING JOSEPH JSenior Vice PresidentMar 01Sale58.981,43084,34438,466Mar 02 05:14 PM
Contreras JaimeSenior Vice PresidentMar 01Sale59.746,284375,38150,436Mar 02 05:13 PM
Funck Robert ESenior Vice PresidentMar 01Sale58.991,22071,970104,493Mar 02 05:11 PM
BIRD ROGERSenior Vice PresidentMar 01Sale58.801,64596,72866,436Mar 02 05:13 PM
Bracken Sharon JSenior Vice PresidentMar 01Sale58.931,05362,05646,390Mar 02 05:09 PM
STARKS DANIEL JDirectorFeb 27Buy60.7729,5541,795,9017,012,839Feb 28 06:35 PM
STARKS DANIEL JDirectorFeb 27Buy60.8740024,3487,013,239Feb 28 06:36 PM
STARKS DANIEL JDirectorFeb 27Buy60.6740,0372,429,2376,983,285Feb 28 06:34 PM
Fussell Stephen RExecutive Vice PresidentFeb 20Option Exercise38.40104,6424,018,253289,526Feb 21 07:23 PM
Fussell Stephen RExecutive Vice PresidentFeb 20Sale59.7342,7092,550,813190,416Feb 21 07:23 PM
Watkin JaredSenior Vice PresidentFeb 20Sale59.2929717,60973,377Feb 21 06:21 PM
PEDERSON MICHAEL JSenior Vice PresidentFeb 20Sale59.2945927,21382,069Feb 21 06:18 PM
Fussell Stephen RExecutive Vice PresidentFeb 20Sale59.845,532331,048184,884Feb 21 07:24 PM
Fussell Stephen RExecutive Vice PresidentFeb 20Sale59.6156,4013,361,948233,125Feb 21 07:23 PM